Personalized Medicine Market By Application(Health Informatics, Clinical Research, Companion Diagnostics, Biomarker Identification), By End-user(Hospitals, Contract Research Organizations, Molecular Diagnostic Laboratories and Testing facilities Academic Institutes and Research Laboratories, Bio and health informatics companies), By Therapeutic Area(Cardiology, Antiviral, Psychiatry, Oncology, Neurology), Industry Trends, Estimation & Forecast, 2017 - 2025

Publication Month: Dec 2019 | No. of Pages: 159 Published By: Esticast Research & Consulting
Single User License: US $ 4700
Corporate User License: US $ 5600

"Personalized Medicine Market" 2018-2026 report is a professional study on the current state of the market that focuses on the major drivers, challenges, opportunities for the leading players. The research report also offers a granular analysis of various definitions, and classification of the industry, applications of the industry, regional breakdown, opportunities, challenges, and chain structure.

About Personalized Medicine Market

Personalized medication is an advanced version of the conventional approaches for the treatment of diseases on an individual level. It is a process of diagnosing and preventing a disease by providing treatment to a patient using the information regarding his/her genetic structure, proteins, and the external environment. It's a methodology which is based upon the analysis of unique risks associated to a specific person regarding specific diseases. The major advantage of this medicine therapy is that, it incorporates the usage of highly precise equipment and tools, coupled with specialized doctors who determine the treatment on the basis of patient's molecular profile after the analysis of harmful side effects. This saves the patient from unnecessary delay in the treatment and extra cost which is caused by the conventional trial and error approach. There are various funded programs supported by the European Union for the development of biotechnology research and personalized medicine. For example, the EU has already sanctioned a fund of more than 3 billion euros for the personalized medication research.

Market Summary:

The Personalized Medicine market is a comprehensive report which offers a meticulous overview of the market share, size, trends, demand, product analysis, application analysis, regional outlook, competitive strategies, forecasts, and strategies impacting the Personalized Medicine Industry. The report includes a detailed analysis of the market competitive landscape, with the help of detailed business profiles, SWOT analysis, project feasibility analysis, and several other details about the key companies operating in the market.

The study on the worldwide Personalized Medicine market strives to offer substantial and profound insights into the current market scenario and the developing growth dynamics. Moreover, the report also provides the market players along with the new contenders a complete view of the market landscape. The inclusive research will enable the well-established as well as the entry-level players to establish their business strategies and accomplish their short-term and long-term goals.

Scope and Segmentation of the Report

The segment analysis is one of the significant sections of this report. Our expert analyst has categorized the market into product type, application/end-user, and geography. All the segments are analyzed based on their market share, growth rate, and growth potential. In the geographical classification, the report highlights the regional markets having high growth potential. This thorough evaluation of the segments would help the players to focus on revenue-generating areas of the Personalized Medicine market.

Based on Type

By Therapeutic area

Cardiology
Antiviral
Psychiatry
Oncology
Neurology
Others

Based on Application

Health Informatics
Clinical Research
Companion Diagnostics
Biomarker identification

Regional Analysis

Our analysts are experts in covering all types of geographical markets from developing to mature ones. You can expect a comprehensive research analysis of key regional and country-level markets such as Europe, North America, South America, Asia-Pacific, and the Middle East & Africa. With accurate statistical patterns and regional classification, our domain experts provide you one of the most detailed and easily understandable regional analyses of the Personalized Medicine market.

Competitive Landscape:

The research report also studied the key players operating in the Personalized Medicine market. It has evaluated and explained the research & development stages of these companies, their financial performances, and their expansion plans for the coming years. Moreover, the research report also includes the list of planned initiatives that clearly explain the accomplishments of the companies in the recent past.

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products, etc.):

Abbott Laboratories
ASURAGEN
INC.
bioMerieux SA
Bristol-Myers Squibb
CETICS Healthcare Technologies GmbH
GlaxoSmithKline
IBM Corporation
Illumina
Inc.
Intomics A/S
JOHNSON & JOHNSON
Laboratory Corporation of America
F. Hoffmann-La Roche AG
GE Healthcare
Gilead Sciences
Inc.
Merck KGaA
Novartis AG
Pfizer
Inc.
Quest Diagnostics
Randox Laboratories
SANOFI
Almac Group
Amgen
Inc.
Astellas Pharma
Inc.
AstraZeneca PLC
Teva Pharmaceuticals Limited
Thermo Fisher Scientific

Research Methodology

The research methodology of the market is based on both primary as well as secondary research data sources. It compels different factors affecting the Personalized Medicine industry such as historical data and market trends, different policies of the government, market environment, market risk factors, market restraints, technological advancements, forthcoming innovations, and obstacles in the industry.

The content of the study subjects includes a total of 8 chapters:

Chapter 1, describe the Personalized Medicine market report's - executive summary, market definition, and market scope. Moreover, the report helps in picking up the crucial information about the said market.

Chapter 2, defines the Research Methodology including primary research, assumptions & exclusions, and secondary data sources. The report follows the simultaneous top-down and bottom approach to provide you the accurate market sizing.

Chapter 3, explains the report segmentation & scope, key market trends (drivers, restraints, and opportunities), along with Porter's five forces analysis and market share analysis

Chapter 4: It helps in understanding the key product segments and their future of the Personalized Medicine Market. It provides strategic recommendations in key business segments based on the market estimations.

Chapters 5, and 6 to segment the sales by type and application/end-user, with sales market share and growth rate by type, application/end-user, from 2018 to 2016. Our team of Analysts and experts dedicatedly put their effort to provide you the best possible and accurate segmentation data and analysis.

Chapter 7, describes the regional segmentation based on the country level for the forecast period 2018 - 2026. The research report not only provide the market data of the five geographies but also provide the qualitative as well we qualitative information on country level bifurcation.

Chapter 8, to profile the top manufacturers of Personalized Medicine, with price, sales, revenue and market share of Personalized Medicine in 2016, 2017, and 2018. Players are expected to sign acquisition and collaboration deals to expand their products and services portfolio. Such strategic agreements could help them to improve their client base in other countries and gain a competitive advantage

CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources
CHAPTER 2. PERSONALIZED MEDICINE MARKET OVERVIEW
2.1. PERSONALIZED MEDICINE MARKET INTRODUCTION
2.2. GLOBAL PERSONALIZED MEDICINE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1. Global Personalized Medicine Production (VOLUME) and Growth Rate (%), (2017-2025)
2.3. GLOBAL PERSONALIZED MEDICINE MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1. Global Personalized Medicine Capacity (VOLUME) and Growth Rate (%), (2017-2025)
2.4. GLOBAL PERSONALIZED MEDICINE MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1. Global Personalized Medicine Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
2.5. GLOBAL PERSONALIZED MEDICINE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1. Global Personalized Medicine Consumption (VOLUME) and Growth Rate (%), (2017-2025)
CHAPTER 3. GLOBAL PERSONALIZED MEDICINE MARKET BY THERAPEUTIC AREA, 2017-2025
3.1. CARDIOLOGY
3.2. ANTIVIRAL
3.3. PSYCHIATRY
3.4. GLOBAL PERSONALIZED MEDICINE MARKET REVENUE BY THERAPEUTIC AREA, 2017-2025
3.4.1. Global Personalized Medicine Market Revenue (Million USD) and Share (%) By Therapeutic area, 2017-2025
3.4.2. Cardiology Market Revenue and Growth Rate, 2017-2025
3.4.3. Antiviral Market Revenue and Growth Rate, 2017-2025
3.4.4. Psychiatry Market Revenue and Growth Rate, 2017-2025
3.5. GLOBAL PERSONALIZED MEDICINE MARKET PRODUCTION BY THERAPEUTIC AREA, 2017-2025
3.5.1. Global Personalized Medicine Market Production (Volume) and Share (%) By Therapeutic area, 2017-2025
3.5.2. Cardiology Market Production and Growth Rate, 2017-2025
3.5.3. Antiviral Market Production and Growth Rate, 2017-2025
3.5.4. Psychiatry Market Production and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for other therapeutic area segment.
CHAPTER 4. GLOBAL PERSONALIZED MEDICINE MARKET BY APPLICATION, 2017-2025
4.1. HEALTH INFORMATICS
4.2. COMPANION DIAGNOSTICS
4.3. BIOMARKER IDENTIFICATION
4.4. GLOBAL PERSONALIZED MEDICINE MARKET REVENUE BY APPLICATION, 2017-2025
4.4.1. Global Personalized Medicine Market Revenue (Million USD) and Share (%) By Application, 2017-2025
4.4.2. Health Informatics Market Revenue and Growth Rate, 2017-2025
4.4.3. Companion Diagnostics Market Revenue and Growth Rate, 2017-2025
4.4.4. Biomarker identification Market Revenue and Growth Rate, 2017-2025
4.5. GLOBAL PERSONALIZED MEDICINE MARKET CONSUMPTION BY APPLICATION, 2017-2025
4.5.1. Global Personalized Medicine Market Consumption (Volume) and share (%) By Application, 2017-2025
4.5.2. Health Informatics Market Consumption and Growth Rate, 2017-2025
4.5.3. Companion Diagnostics Market Consumption and Growth Rate, 2017-2025
4.5.4. Biomarker identification Market Consumption and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for other application and end user segment.
CHAPTER 5. GLOBAL PERSONALIZED MEDICINE MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. Canada
5.1.3. Mexico
5.2. EUROPE
5.2.1. U.K.
5.2.2. France
5.2.3. Germany
5.2.4. Italy
5.2.5. Spain
5.2.6. Rest of Europe
5.3. ASIA PACIFIC
5.3.1. China
5.3.2. Japan
5.3.3. India
5.3.4. Korea
5.3.5. Rest of APAC
5.4. SOUTH AMERICA
5.4.1. Brazil
5.4.2. Rest of South America
5.5. REST OF THE WORLD
5.5.1. Middle East
5.5.2. Africa
5.6. GLOBAL PERSONALIZED MEDICINE MARKET REVENUE BY REGION, 2017-2025
5.6.1. Global Personalized Medicine Market Revenue (Million USD) and Share (%) By Region, 2017-2025
5.6.2. North America Market Revenue and Growth Rate, 2017-2025
5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
5.6.5. South America Market Revenue and Growth Rate, 2017-2025
5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 6. GLOBAL PERSONALIZED MEDICINE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
6.1. GLOBAL PERSONALIZED MEDICINE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 35
6.1.1. Global Personalized Medicine Market Production (Volume) and Share (%) By Region, 2017-2025
6.1.2. Global Personalized Medicine Market Consumption (Volume) and Share (%) By Region, 2017-2025
6.1.3. North America Market Production and Consumption, 2017-2025
6.1.4. Europe Market Production and Consumption, 2017-2025
6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
6.1.6. South America Market Production and Consumption, 2017-2025
6.1.7. Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 7. MARKET DETERMINANTS
7.1. MARKET DRIVERS
7.2. MARKET RESTRAINTS
7.3. MARKET OPPORTUNITIES
7.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 8. GLOBAL PERSONALIZED MEDICINE MARKET COMPETITION BY MANUFACTURERS
8.1. GLOBAL PERSONALIZED MEDICINE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
8.1.1. Global Personalized Medicine Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
8.2. GLOBAL PERSONALIZED MEDICINE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
8.2.1. Global Personalized Medicine Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
8.3. PERSONALIZED MEDICINE MARKET COMPETITIVE SITUATION AND TRENDS
8.3.1. Personalized Medicine Market Share (%) of Top 3 Manufacturers
8.3.2. Personalized Medicine Market Share (%) of Top 5 Manufacturers
CHAPTER 9. GLOBAL PERSONALIZED MEDICINE MANUFACTURERS ANALYSIS
9.1. ABBOTT LABORATORIES
9.1.1. Business Overview
9.1.2. Company Basic Information
9.1.3. Personalized Medicine Product Details
9.1.4. Abbott Laboratories Personalized Medicine Production, Revenue and Gross Margin
9.2. ASURAGEN, INC.
9.2.1. Business Overview
9.2.2. Company Basic Information
9.2.3. Personalized Medicine Product Details
9.2.4. ASURAGEN, INC. Personalized Medicine Production, Revenue and Gross Margin
9.3. BIOMERIEUX SA
9.3.1. Business Overview
9.3.2. Company Basic Information
9.3.3. Personalized Medicine Product Details
9.3.4. BioMerieux SA Personalized Medicine Production, Revenue and Gross Margin
9.4. BRISTOL-MYERS SQUIBB
9.4.1. Business Overview
9.4.2. Company Basic Information
9.4.3. Personalized Medicine Product Details
9.4.4. Bristol-Myers Squibb Personalized Medicine Production, Revenue and Gross Margin
9.5. CETICS HEALTHCARE TECHNOLOGIES GMBH
9.5.1. Business Overview
9.5.2. Company Basic Information
9.5.3. Personalized Medicine Product Details
9.5.4. CETICS Healthcare Technologies GmbH Personalized Medicine Production, Revenue and Gross Margin
9.6. GLAXOSMITHKLINE
9.6.1. Business Overview
9.6.2. Company Basic Information
9.6.3. Personalized Medicine Product Details
9.6.4. GlaxoSmithKline Personalized Medicine Production, Revenue and Gross Margin
9.7. IBM CORPORATION
9.7.1. Business Overview
9.7.2. Company Basic Information
9.7.3. Personalized Medicine Product Details
9.7.4. IBM Corporation Personalized Medicine Production, Revenue and Gross Margin
9.8. ILLUMINA, INC.
9.8.1. Business Overview
9.8.2. Company Basic Information
9.8.3. Personalized Medicine Product Details
9.8.4. Illumina, Inc. Personalized Medicine Production, Revenue and Gross Margin
9.9. LABORATORY CORPORATION OF AMERICA
9.9.1. Business Overview
9.9.2. Company Basic Information
9.9.3. Personalized Medicine Product Details
9.9.4. Laboratory Corporation of America Personalized Medicine Production, Revenue and Gross Margin
9.10. F. HOFFMANN-LA ROCHE AG
9.10.1. Business Overview
9.10.2. Company Basic Information
9.10.3. Personalized Medicine Product Details
9.10.4. F. Hoffmann-La Roche AG Personalized Medicine Production, Revenue and Gross Margin
CHAPTER 10. PERSONALIZED MEDICINE MARKET VALUE CHAIN ANALYSIS
10.1. PERSONALIZED MEDICINE INDUSTRIAL CHAIN ANALYSIS
10.2. PERSONALIZED MEDICINE KEY RAW MATERIALS ANALYSIS
10.2.1. Key Raw Materials
10.2.2. Price Trend of Key Raw Materials
10.2.3. Key Suppliers of Raw Materials
10.3. CONSUMER ANALYSIS
10.3.1. Consumer 1
10.3.2. Consumer 2
10.3.3. Consumer 3
10.3.4. Consumer 4

Tables and Figures



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets